Safety and performance of photobiomodulation delivered by vaginal probe in patients with genitourinary syndrome of menopause
Even when applying a broad definition for adverse events, these preliminary data suggested that PBMT using the MILTA GYNECO vaginal probe was safe, with high patient satisfaction. The next step is to assess the efficacity of the medical device in a randomized trial.
Authors
- Jennifer Salerno (ORCID: https://orcid.org/0000-0001-7282-5579)
- Renaud de Tayrac (ORCID: https://orcid.org/0000-0002-4352-4782)
- Thierry Chevallier (ORCID: https://orcid.org/0000-0002-5110-6273)
- Chris Serrand (ORCID: https://orcid.org/0000-0002-6074-8577)
- Sarah Kabani (ORCID: https://orcid.org/0000-0001-9730-8885)
- P. Marès
Institutions
- Inserm (FR)
- Centre Hospitalier Universitaire de Nîmes (FR)
- Institute for Neurosciences of Montpellier (FR)
- Université de Nîmes (FR)
Publication Details
- Journal
- Climacteric
- Published
- 2025-12-17
- DOI
- https://doi.org/10.1080/13697137.2025.2591279
- Primary Topic
- Menopause: Health Impacts and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00